Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience
- 22 December 2014
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 239 (1), 93-100
- https://doi.org/10.1016/j.atherosclerosis.2014.12.036
Abstract
No abstract availableKeywords
Funding Information
- University of Western Australia
This publication has 52 references indexed in Scilit:
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial HypercholesterolemiaCirculation: Cardiovascular Genetics, 2012
- Screening for familial hypercholesterolaemiaPathology, 2012
- Multicenter Study to Determine the Diagnosis Criteria of Heterozygous Familial Hypercholesterolemia in JapanJournal of Atherosclerosis and Thrombosis, 2012
- Familial hypercholesterolaemia: A model of care for AustralasiaAtherosclerosis Supplements, 2011
- Mechanisms of Disease: genetic causes of familial hypercholesterolemiaNature Clinical Practice Cardiovascular Medicine, 2007
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004
- A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemiaAtherosclerosis, 2003
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991